1/13/2016 - $0.95 (low)

5/2/2016 - $1.87 (high)

2016 Potential Catalyst
1. P: Phase 2a top-line data - Q2

P Phase 2a Timelines

3/17/2016 - Last patient visit
3/17/2016 - Run-up started with +29% on ~900K volume ($1.56 closing price)
3/18/2016 - Run-up continued with +14% on ~600K volume ($1.78 closing price)
5/24/2016 - Top-line result

What tax-loss selling?

11/01/2016 - $1.16
12/30/2016 - $1.16

5/10/2017 - $0.63 (low)

2017 high - ?

2017 Potential Catalysts
1. B-OM: top-line data - November/December
2. P: Phase 2b top-line data - December/January
3. K-OC: interim data - Q4